Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anne Blaes

Showing results (71-80 of 81) with videos related to

Pageof 9
Sort By:
NPJ Breast Cancer|April 15, 2025
Multicenter retrospective cohort study of the sequential use of the antibody-drug conjugates (ADCs) trastuzumab deruxtecan (T-DXd) and sacituzumab govitecan (SG) in patients with HER2-low metastatic breast cancer (MBC)Laura A Huppert, Reshma Mahtani, Samantha Fisch, et al.
Journal of Cardiac Failure|October 17, 2024
Cardio-Oncology and Heart Failure: a Scientific Statement From the Heart Failure Society of AmericaMichelle Weisfelner Bloom, Jacqueline B Vo, Jo E Rodgers, et al.
Cardio-Oncology (London, England)|May 29, 2026
Prevention and management of cardiovascular disease in adults with cancer: an International Cardio-Oncology Society (IC-OS) and Multinational Association of Supportive Care in Cancer (MASCC) clinical practice statementSusan Dent, Michelle B Nadler, Anne Blaes, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 4, 2020
A Randomized Phase IIb Study of Low-dose Tamoxifen in Chest-irradiated Cancer Survivors at Risk for Breast CancerSmita Bhatia, Melanie R Palomares, Lindsey Hageman, et al.
CA: a Cancer Journal for Clinicians|September 10, 2020
Cardio-oncology care in the era of the coronavirus disease 2019 (COVID-19) pandemic: An International Cardio-Oncology Society (ICOS) statementDaniel Lenihan, Joseph Carver, Charles Porter, et al.
Journal of Cardiac Failure|April 4, 2016
Cardio-Oncology Training: A Proposal From the International Cardioncology Society and Canadian Cardiac Oncology Network for a New Multidisciplinary SpecialtyDaniel J Lenihan, Gregory Hartlage, Jeanne DeCara, et al.
Cancer Medicine|March 27, 2026
Standardizing the Clinical Approach to Cancer Therapy-Related Cardiac Dysfunction: Applying Cardio-Oncology Guidelines as a Practical Tool for Hematology and Oncology ProvidersAbdelrahman Ali, Suparna C Clasen, Anne Blaes, et al.
Nature Communications|March 31, 2025
Treatment, toxicity, and mortality after subsequent breast cancer in female survivors of childhood cancerCindy Im, Hasibul Hasan, Emily Stene, et al.
European Heart Journal|December 14, 2021
Defining cardiovascular toxicities of cancer therapies: an International Cardio-Oncology Society (IC-OS) consensus statementJoerg Herrmann, Daniel Lenihan, Saro Armenian, et al.
Cardio-Oncology (London, England)|December 9, 2020
Perspectives on the COVID-19 pandemic impact on cardio-oncology: results from the COVID-19 International Collaborative Network surveyDiego Sadler, Jeanne M DeCara, Joerg Herrmann, et al.
Pageof 9

Showing results (71-80 of 81) with videos related to

Sort By:
Pageof 9
NPJ Breast Cancer|April 15, 2025
Multicenter retrospective cohort study of the sequential use of the antibody-drug conjugates (ADCs) trastuzumab deruxtecan (T-DXd) and sacituzumab govitecan (SG) in patients with HER2-low metastatic breast cancer (MBC)Laura A Huppert, Reshma Mahtani, Samantha Fisch, et al.
Journal of Cardiac Failure|October 17, 2024
Cardio-Oncology and Heart Failure: a Scientific Statement From the Heart Failure Society of AmericaMichelle Weisfelner Bloom, Jacqueline B Vo, Jo E Rodgers, et al.
Cardio-Oncology (London, England)|May 29, 2026
Prevention and management of cardiovascular disease in adults with cancer: an International Cardio-Oncology Society (IC-OS) and Multinational Association of Supportive Care in Cancer (MASCC) clinical practice statementSusan Dent, Michelle B Nadler, Anne Blaes, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 4, 2020
A Randomized Phase IIb Study of Low-dose Tamoxifen in Chest-irradiated Cancer Survivors at Risk for Breast CancerSmita Bhatia, Melanie R Palomares, Lindsey Hageman, et al.
CA: a Cancer Journal for Clinicians|September 10, 2020
Cardio-oncology care in the era of the coronavirus disease 2019 (COVID-19) pandemic: An International Cardio-Oncology Society (ICOS) statementDaniel Lenihan, Joseph Carver, Charles Porter, et al.
Journal of Cardiac Failure|April 4, 2016
Cardio-Oncology Training: A Proposal From the International Cardioncology Society and Canadian Cardiac Oncology Network for a New Multidisciplinary SpecialtyDaniel J Lenihan, Gregory Hartlage, Jeanne DeCara, et al.
Cancer Medicine|March 27, 2026
Standardizing the Clinical Approach to Cancer Therapy-Related Cardiac Dysfunction: Applying Cardio-Oncology Guidelines as a Practical Tool for Hematology and Oncology ProvidersAbdelrahman Ali, Suparna C Clasen, Anne Blaes, et al.
Nature Communications|March 31, 2025
Treatment, toxicity, and mortality after subsequent breast cancer in female survivors of childhood cancerCindy Im, Hasibul Hasan, Emily Stene, et al.
European Heart Journal|December 14, 2021
Defining cardiovascular toxicities of cancer therapies: an International Cardio-Oncology Society (IC-OS) consensus statementJoerg Herrmann, Daniel Lenihan, Saro Armenian, et al.
Cardio-Oncology (London, England)|December 9, 2020
Perspectives on the COVID-19 pandemic impact on cardio-oncology: results from the COVID-19 International Collaborative Network surveyDiego Sadler, Jeanne M DeCara, Joerg Herrmann, et al.
Pageof 9